Sandbox 2: Difference between revisions

Jump to navigation Jump to search
Aditya Ganti (talk | contribs)
No edit summary
Aditya Ganti (talk | contribs)
Line 3: Line 3:
*''Strongyloides stercoralis''
*''Strongyloides stercoralis''
:* Preferred regimen (1): [[Ivermectin]] 200 μg/kg/day PO q24h for 2 days  
:* Preferred regimen (1): [[Ivermectin]] 200 μg/kg/day PO q24h for 2 days  
:* Note: For immunocompromised patients several treatment courses at 2-week intervals is recommended.
:** Note: For immunocompromised patients several treatment courses at 2-week intervals is recommended.
:* Alternative regimen (1): [[Thiabendazole]] 1.5 g PO q24h for 2 consecutive days.
:* Alternative regimen (1): [[Thiabendazole]] 1.5 g PO q24h for 2 consecutive days.
:* Note: The maximum dosage is 3 g/d every 2 days (this dosage is likely to be toxic and needs to be reduced)
:** Note: The maximum dosage is 3 g/d every 2 days (this dosage is likely to be toxic and needs to be reduced)
:* Note: Cure rates as high as 87% to 94%, but the drug may not be effective in the disease that is disseminated beyond the gastrointestinal tract.
:** Note: Cure rates are as high as 87% to 94%, but the drug may not be effective in the disease that is disseminated beyond the gastrointestinal tract.
:* Note: Many patients have gastrointestinal adverse effects, it is used rarely in the U.S. because of adverse effects
:** Note: Many patients have gastrointestinal adverse effects, it is used rarely in the U.S. because of adverse effects
:* Alternative regimen (2): [[Albendazole]] 400 mg PO bid for 3 days
:* Alternative regimen (2): [[Albendazole]] 400 mg PO bid for 3 days



Revision as of 15:12, 9 August 2017

Medical therapy

Uncomplicated strongylidiasis

  • Strongyloides stercoralis
  • Preferred regimen (1): Ivermectin 200 μg/kg/day PO q24h for 2 days
    • Note: For immunocompromised patients several treatment courses at 2-week intervals is recommended.
  • Alternative regimen (1): Thiabendazole 1.5 g PO q24h for 2 consecutive days.
    • Note: The maximum dosage is 3 g/d every 2 days (this dosage is likely to be toxic and needs to be reduced)
    • Note: Cure rates are as high as 87% to 94%, but the drug may not be effective in the disease that is disseminated beyond the gastrointestinal tract.
    • Note: Many patients have gastrointestinal adverse effects, it is used rarely in the U.S. because of adverse effects
  • Alternative regimen (2): Albendazole 400 mg PO bid for 3 days

Complicated strongyloidiasis (Disseminated or hyper-infection syndrome)

  • Preferred regimen (1): Ivermectin 200 μg/kg/d PO q24h orally for at least 7 to 10 days (until larvae are no longer detected in stool, sputum, or urine)
  • Note: For hyper-infection and disseminated disease, adding albendazole (400 mg PO bid for 7 days) to ivermectin may be warranted.